WE DO WE MAKE and keep commitments. with urgency. Updated Full-Year 2023 Financial Guidance •Increased full-year adjusted cash EPS guidance to $3.30 - $3.50, from the prior range of $3.20 – $3.45, which continues to include between $0.20 and $0.25 of FX headwind Warehouse Software Implementation Update • Exited 2022 with approximately $30M of WMS related shippable backlog • Focus is on continuing to regain volumes that were affected by the disruption. The ultimate impact remains unknown, however, orders wer ...

CONMED Corporation (NYSE:CNMD) Q1 2023 Results Earnings Conference Call April 27, 2023 4:30 PM ET Company Participants Curt Hartman - Chair of the Board, President, and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Lilia-Celine Lozada - J.P. Morgan Ian Tolle - Bank of America Securities Vik Chopra - Wells Fargo Corporate & Investment Banking Matthew O'Brien - Piper Sandler Mike Matson - Needham & Company M ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...

Common Stock, $0.01 par value CNMD NYSE Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorte ...

CONMED Corporation (NYSE:CNMD) Q4 2022 Earnings Conference Call February 2, 2023 4:30 PM ET Company Participants Curt Hartman - Chair of the Board, President, and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Robbie Marcus - JPMorgan Rick Wise - Stifel Matt O'Brien - Piper Sandler Young Li - Jefferies Mike Matson - Needham Matthew Mishan - KeyBanc Operator Good afternoon, everyone. Before the ...

Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer November 15, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's ...

CONMED Corporation (NYSE:CNMD) Q3 2022 Earnings Conference Call October 26, 2022 4:30 PM ET Company Representatives Curt Hartman - Chair of the Board, President, Chief Executive Officer Todd Garner - Executive Vice President, Chief Financial Officer Conference Call Participants Mike Matson - Needham Young Li - Jefferies Robbie Marcus - J.P. Morgan Matthew Mishan - KeyBanc Matt O'Brien - Piper Sandler Rick Wise - Stifel Travis Steed - Bank of America Securities Operator Good afternoon, everyone. Before the c ...

Investor Presentation Q3 2022 Earnings Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer October 26, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...

CONMED Corporation (NYSE:CNMD) Q2 2022 Earnings Conference Call July 27, 2022 4:30 PM ET Company Participants Curt Hartman - Chairman, President & Chief Executive Officer Pat Beyer - President, CONMED International & Global Orthopaedics Todd Garner - Executive Vice President & Chief Financial Officer Conference Call Participants Rick Wise - Stifel Robbie Marcus - JPMorgan Travis Steed - Bank of America Mike Matson - Needham & Company Matt O'Brien - Piper Sandler Matthew Mishan - KeyBanc Capital Operator Goo ...